Candel Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -16.6% | +133.0% | -12.0% | -47.5% | +159.4% | +17.2% | |
| – | -22.3% | +141.7% | -15.3% | -48.9% | +182.1% | +15.3% | |
| – | +576.8% | +135.8% | -15.2% | -49.5% | +189.9% | +16.6% | |
| – | -22.2% | +135.8% | -15.2% | -49.5% | +189.9% | +16.6% | |
| – | +555.8% | +37.6% | +42.9% | – | – | – | |
| – | +14.7% | -59.5% | +22.9% | -7.6% | +42.5% | +80.7% | |
| – | +234.3% | +13.8% | +4.7% | +152.6% | +164.6% | -76.0% | |
| – | – | – | – | +1,927.2% | +11.2% | -95.7% | |
| – | +322.5% | +72.6% | -76.1% | +11.1% | -43.8% | +376.4% | |
| – | +15.0% | +15.9% | +3,623.2% | -40.6% | -79.0% | +1,710.6% | |
| – | – | – | -25.6% | -73.3% | +420.4% | -21.7% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +0.8% | +52.7% | +0.4% | +9.5% | +67.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.